Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.45
-0.01 (-0.18%)
At close: Apr 28, 2026, 4:00 PM EDT
5.20
-0.25 (-4.59%)
After-hours: Apr 28, 2026, 4:30 PM EDT
Quoin Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.49 | 5.93 | 6.07 | 6.58 | 4.5 | |
| Research & Development | 9.8 | 3.6 | 3.31 | 2.67 | 1.56 | |
| Operating Expenses | 16.29 | 9.53 | 9.38 | 9.26 | 6.06 | |
| Operating Income | -16.29 | -9.53 | -9.38 | -9.26 | -6.06 | |
| Interest Expense | - | - | - | -0.71 | -1.37 | |
| Interest & Investment Income | 0.48 | 0.56 | 0.69 | 0.1 | - | |
| Other Non Operating Income (Expenses) | 0 | 0.01 | -0 | 0.08 | -12.78 | |
| EBT Excluding Unusual Items | -15.8 | -8.96 | -8.69 | -9.8 | -20.21 | |
| Other Unusual Items | - | - | - | 0.42 | -1.25 | |
| Pretax Income | -15.8 | -8.96 | -8.69 | -9.38 | -21.46 | |
| Net Income | -15.8 | -8.96 | -8.69 | -9.38 | -21.46 | |
| Preferred Dividends & Other Adjustments | - | - | - | 0.07 | - | |
| Net Income to Common | -15.8 | -8.96 | -8.69 | -9.45 | -21.46 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | - | - | |
| Shares Change (YoY) | 710.69% | 411.86% | - | - | - | |
| EPS (Basic) | -14.80 | -68.02 | -337.46 | - | - | |
| EPS (Diluted) | -14.80 | -68.02 | -337.46 | - | - | |
| EBITDA | -16.19 | -9.43 | -9.27 | -9.15 | -5.96 | |
| D&A For EBITDA | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| EBIT | -16.29 | -9.53 | -9.38 | -9.26 | -6.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.